Physician

Matthew John Kapalis, DO

According to 2025 Medicare claims, Matthew Kapalis, DO (NPI: 1003058173) practices cardiac electrophysiology in the Lincoln, NE market, with the plurality of this provider's patient population coming from Lancaster, NE. This provider's primary affiliated billing organization is INTEGRATED CARDIOLOGY GROUP LLC (NPI: 1982653515; TIN: 470844961) and primary practice location at 68506-1275. Kapalis is affiliated with the Nebraska Health Network, LLC (ACO ID: A3273), NPG Health Collaborative LLC (ACO ID: A3287), and Bryan Health Connect ACO, LLC (ACO ID: A4573), participating under the MSSP model.

Kapalis' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 6,894 traditional Medicare patients, billed 16,770 HCPCS/CPT codes, and received $463,317 in Medicare payments. The top billing code was 93297 (Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days). Part D data shows 1,112 prescription claims across 282 beneficiaries totaling $311,122 in drug costs, led by Xarelto (Rivaroxaban). Open Payments data shows 29 records totaling $2,645. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $49,980 to $463,317. Similarly, Part D prescription costs have risen steadily, from $15,843 to $311,122. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,031	1,637	$49,980
2016	1,331	3,079	$193,618
2017	1,067	4,101	$274,676
2018	1,189	5,037	$281,669
2019	1,226	5,155	$268,470
2020	3,830	7,450	$378,445
2021	5,687	12,026	$476,358
2022	5,878	14,147	$456,786
2023	5,464	13,515	$388,784
2024	6,894	16,770	$463,317

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	31	155	$15,843
2016	78	385	$41,088
2017	126	547	$54,396
2018	157	744	$109,662
2019	178	810	$144,169
2020	155	510	$103,542
2021	197	813	$157,521
2022	240	1,060	$264,159
2023	243	965	$286,935
2024	282	1,112	$311,122

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93297	Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days	511	778	$39
93294	Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days	1,590	2,577	$18
93296	Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days	2,046	3,308	$13
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	1,636	1,850	$9
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	3,283	4,309	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xarelto	Rivaroxaban	174	7,951	$144,934
Eliquis	Apixaban	137	5,752	$113,661
Multaq	Dronedarone Hcl	27	1,410	$35,232
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	13	390	$2,224
Metoprolol Succinate	Metoprolol Succinate	224	12,467	$2,068

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	29	$2,645	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Matthew John Kapalis, DO?

Tedicare shows public-source Medicare data for Matthew John Kapalis, DO (NPI 1003058173), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Matthew John Kapalis, DO have ACO affiliation data?

Matthew John Kapalis, DO is shown with ACO affiliation data for Nebraska Health Network, LLC (MSSP, ACO ID A3273), NPG Health Collaborative LLC (MSSP, ACO ID A3287), and Bryan Health Connect ACO, LLC (MSSP, ACO ID A4573).

What billing organization is linked to Matthew John Kapalis, DO?

Matthew John Kapalis, DO is linked to INTEGRATED CARDIOLOGY GROUP LLC (billing NPI 1982653515) in the available physician profile data.

Does Matthew John Kapalis, DO have Open Payments data?

Matthew John Kapalis, DO has 29 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.